Vorapaxar sulfate

CAS : 705260-08-8

Ref. 3D-FV28721

Informations sur le produit

• Nom: Vorapaxar sulfate
• Synonymes: N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-Fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]c arbamic acid ethyl ester sulfateSch 530348, Carbamic acid, N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]-, ethyl ester, sulfate (1:1), Carbamic acid, [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]-, ethyl ester, sulfate (1:1), Sch 530348, Vorapaxar sulphate, Zontivity
• CAS: 705260-08-8

Description

Vorapaxar sulfate is a platelet aggregation inhibitor that is used to prevent thrombosis. It inhibits the activation of human platelets by inhibiting the binding of thrombin to its receptor on the surface of platelets, which prevents the production of fibrinogen. Vorapaxar sulfate has been shown to be effective in reducing intracranial haemorrhage and ischaemic attack in patients with stroke or transient ischaemic attack. Vorapaxar sulfate also has anti-inflammatory properties, which may be due to its inhibition of prostaglandin synthesis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 590.66 g/mol
• Formule: C₂₉H₃₅FN₂O₈S
• Degré de pureté: Min. 95%